North America Anchors Colgate As Currency Headwinds Continue Abroad
This article was originally published in The Pink Sheet
Executive Summary
Innovation across categories helped make Colgate's North American business its star segment in the second quarter, rising 1.6% to $793m on strong oral care sales, while the firm’s international business remains impacted negatively by currency headwinds.
You may also be interested in...
Colgate Mitigates Currency Crush Via Oral-Care Sales, Price Hikes
Price increases in some regions were critical to earnings in Colgate's second quarter, and will continue to be executed at the expense of volume as needed, while oral-care product launches also are helping to offset negative currency effects, the firm reported July 30. With an oral-care business that is “one of the few remaining category killers,” Colgate should consider divesting its home-care and pet-product businesses, an analyst suggests.
Colgate Deflects Currency Crush Through Oral Care Sales, Price Hikes
Price increases in some regions are crucial to its earnings while Colgate also looks to oral care product launches as sales drivers. With an oral care business that is “one of the few remaining category killers,” the firm could create more value by divesting its home care and pet product businesses, an analyst says.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.